Read + Share
Amedeo Smart
Independent Medical Education
Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, et al. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science 2021 Nov 2:eabl4784. doi: 10.1126/science.abl4784.PMID: 34726479
Email
LinkedIn
Facebook
Twitter
Privacy Policy